Literature DB >> 15727719

The cost effectiveness of cardiovascular medicines.

Joel Hay1.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15727719     DOI: 10.1007/s11883-005-0026-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  7 in total

1.  Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures.

Authors:  L L Leape; R E Park; T M Bashore; J K Harrison; C J Davidson; R H Brook
Journal:  Am Heart J       Date:  2000-01       Impact factor: 4.749

2.  Hospital cost drivers: an evaluation of 1998-2001 state-level data.

Authors:  Joel W Hay
Journal:  Am J Manag Care       Date:  2003-06       Impact factor: 2.229

3.  Health spending rebound continues in 2002.

Authors:  Katharine Levit; Cynthia Smith; Cathy Cowan; Art Sensenig; Aaron Catlin
Journal:  Health Aff (Millwood)       Date:  2004 Jan-Feb       Impact factor: 6.301

Review 4.  How good is the quality of health care in the United States?

Authors:  M A Schuster; E A McGlynn; R H Brook
Journal:  Milbank Q       Date:  1998       Impact factor: 4.911

5.  Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

6.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

7.  Current trends in the cardiovascular clinical trial arena (I).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.